Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hui Ming Chua"'
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0301396 (2024)
BackgroundIn the search for better anticancer drugs, computer-aided drug design (CADD) techniques play an indispensable role in facilitating the lengthy and costly drug discovery process especially when natural products are involved. Anthraquinone is
Externí odkaz:
https://doaj.org/article/46c1825e0b8e439bacb524fcba37d63c
Publikováno v:
PLoS ONE, Vol 18, Iss 9 (2023)
There is still unmet medical need in cancer treatment mainly due to drug resistance and adverse drug events. Therefore, the search for better drugs is essential. Computer-aided drug design (CADD) and discovery tools are useful to streamline the lengt
Externí odkaz:
https://doaj.org/article/9d63ffd19bdd4712bfc39e28e0a1b5dc
Autor:
Hui Ming Chua, Nathalie Hauet Richer, Magda Swedrowska, Stephen Ingham, Stephen Tomlin, Ben Forbes
Publikováno v:
Pharmaceutics, Vol 8, Iss 1, p 2 (2016)
Circadin 2 mg prolonged-release tablet is the only licensed melatonin product available in the UK. Circadin is indicated for patients with primary insomnia aged 55 and over, but is more widely used “off-label” to treat sleep disorders especially
Externí odkaz:
https://doaj.org/article/50a695050b364da487da8c921e4d2d6c
Autor:
Hye-Na Kang, Robin Thorpe, Ivana Knezevic, Daehyun Baek, Parichard Chirachanakul, Hui Ming Chua, Dina Dalili, Freddie Foo, Kai Gao, Suna Habahbeh, Hugo Hamel, Edwin Nkansah, Maria Savkina, Oleh Semeniuk, Shraddha Srivastava, João Tavares Neto, Meenu Wadhwa, Teruhide Yamaguchi
Publikováno v:
Generics and Biosimilars Initiative Journal. 10:4-32
The World Health Organization has provided specific guidance for biosimilar products to assist regulators, manufacturers and other professionals involved in the development and evaluation of these products. The development and approval of biosimilars
Autor:
Hui Ming Chua, Mumbi Bernice Chilufya, Parichard Chirachanakul, Jacqueline Rodgers, Maria Savkina, Kai Gao, Hugo Hamel, Violeta Pérez Rodríguez, Suna Habahbeh, João Tavares Neto, Mary Casas Levano, Teruhide Yamaguchi, Hye Na Kang, Gi Hyun Kim, Dina Dalili, Freddie Foo, Oleh Semeniuk, Robin Thorpe, Desi Eka Putri, Ivana Knezevic, Shraddha Srivastava, Meenu Wadhwa
Publikováno v:
Annals of the New York Academy of Sciences
The World Health Organization (WHO) issued guidelines for the regulatory evaluation of biosimilars in 2009 and has provided considerable effort toward helping member states implement the evaluation principles in the guidelines into their regulatory p
Autor:
Meenu Wadhwa, Hye-Na Kang, Teeranart Jivapaisarnpong, Lucia Rizka Andalucia, Carolina Damas Rocha Zarate Blades, Mary Casas Levano, Weihong Chang, Jing Yin Chew, Mumbi Bernice Chilufya, Parichard Chirachanakul, Heeyoun (Gloria) Cho, Yi O. Cho, Kyung Min Choi, Sannie Chong, Hui Ming Chua, Ali Vasheghani Farahani, Mumun Gencoglu, Mariam Raouf Wefky Ghobrial, Prasunkumar Guha, Maria-Teresa Gutierrez Lugo, Sung Bae Ha, Suna Habahbeh, Hugo Hamel, Yeosun Hong, Aleksei Iarutkin, Hyunsook Jang, Ramalingam Jayachandran, Dong-young Kim, Gi Hyun Kim, Yunjeong Kim, Hyuk-Sang Kwon, Jacob Larsen, Aileen HyoJu Lee, Jiyoung Lee, Ksenia Medvedeva, Zuma Munkombwe, IlUng Oh, Jooyoung Park, Desi Eka Putri, Jacqueline Rodgers, Sungmun Ryu, Maria Savkina, Thomas Schreitmueller, Oleh Semeniuk, Mira Seo, Yung In Shin, Jinho Shin, Shraddha Srivastava, HyeonHo Song, Suwon Song, João Tavares Neto, Teruhide Yamaguchi, Hyun-Jun (David) Youn, Minae Yun, Aziza Ahmed
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization. 65
The first global workshop on implementation of the WHO guidelines on procedures and data requirements for changes to approved biotherapeutic products adopted by the WHO Expert Committee in 2018 was held in June 2019. The workshop participants recogni
Autor:
Siew Siang Chua1 chuass@um.edu.my, Hui Ming Chua1, Omar, Asma2, Chua, Siew Siang3 (AUTHOR), Chua, Hui Ming (AUTHOR)
Publikováno v:
European Journal of Pediatrics. May2010, Vol. 169 Issue 5, p603-611. 9p. 2 Charts, 2 Graphs.
Autor:
Nathalie Hauet Richer, Stephen Tomlin, Magda Swedrowska, Stephen Ingham, Ben Forbes, Hui Ming Chua
Publikováno v:
Pharmaceutics
Pharmaceutics; Volume 8; Issue 1; Pages: 2
Chua, H M, Hauet Richer, N, Swedrowska, M, Ingham, S & Forbes, B 2016, ' Dissolution of intact, divided and crushed circadin tablets : Prolonged vs. Immediate release of melatonin ', Molecular Pharmaceutics, vol. 8, no. 1 . https://doi.org/10.3390/pharmaceutics8010002
Pharmaceutics, Vol 8, Iss 1, p 2 (2016)
Pharmaceutics; Volume 8; Issue 1; Pages: 2
Chua, H M, Hauet Richer, N, Swedrowska, M, Ingham, S & Forbes, B 2016, ' Dissolution of intact, divided and crushed circadin tablets : Prolonged vs. Immediate release of melatonin ', Molecular Pharmaceutics, vol. 8, no. 1 . https://doi.org/10.3390/pharmaceutics8010002
Pharmaceutics, Vol 8, Iss 1, p 2 (2016)
Circadin 2 mg prolonged-release tablet is the only licensed melatonin product available in the UK. Circadin is indicated for patients with primary insomnia aged 55 and over, but is more widely used “off-label” to treat sleep disorders especially
Publikováno v:
European journal of pediatrics. 169(5)
Paediatric patients are more vulnerable to drug administration errors due to a lack of appropriate drug dosages and strengths for use in this group of patients. Therefore, the aim of the present study was to determine the extent and types of drug adm